伴新月体形成的IgA肾病患者免疫病理表型特点(2)
[2] Moriyama T， Tanaka K， Iwasaki C， et al. Prognosis in IgA nephropathy： 30-year analysis of 1，012 patients at a single center in Japan[J]. Plos One， 2014， 9(3)：e91756.
[3] Trimarchi H， Barratt J， Cattran DC， et al. Oxford Classification of IgA nephropathy 2016-the role of crescentic lesions： an update from the IgA Nephropathy Classification Working Group[J]. Kidney Int， 2017， 91(5)：1014.
[4] Takahiko Ono M D， Liu N， Makino T， et al. Role of mesangial Factor V expression in crescent formation in rat experimental mesangioproliferative glomerulonephritis[J]. J.Pathol， 2004， 204(2)：229-38.
[5] Mcmullen ME， Hart ML， Walsh MC， et al. Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo[J]. Immunobiology， 2006， 211(10)：759-766.
[6] Onda K， Ohi H， Tamano M， et al. Hypercomplementemia in adult patients with IgA nephropathy[J]. J. Clin. Lab. Anal.， 2007， 21(2)：77-84.
[7] Segarra A， Romero K， Agraz I， et al. Mesangial C4d Deposits in Early IgA Nephropathy[J]. Clin J Am SocNephrol， 2018， 13：258-264.
[8] Rosenblad T， Rebetz J， Johansson M， et al. Eculizumab treatment for rescue of renal function in IgA nephropathy[J]. Pediatr.Nephrol.， 2014， 29(11)：2225., http://www.100md.com(杨艳 杨敏)
[3] Trimarchi H， Barratt J， Cattran DC， et al. Oxford Classification of IgA nephropathy 2016-the role of crescentic lesions： an update from the IgA Nephropathy Classification Working Group[J]. Kidney Int， 2017， 91(5)：1014.
[4] Takahiko Ono M D， Liu N， Makino T， et al. Role of mesangial Factor V expression in crescent formation in rat experimental mesangioproliferative glomerulonephritis[J]. J.Pathol， 2004， 204(2)：229-38.
[5] Mcmullen ME， Hart ML， Walsh MC， et al. Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo[J]. Immunobiology， 2006， 211(10)：759-766.
[6] Onda K， Ohi H， Tamano M， et al. Hypercomplementemia in adult patients with IgA nephropathy[J]. J. Clin. Lab. Anal.， 2007， 21(2)：77-84.
[7] Segarra A， Romero K， Agraz I， et al. Mesangial C4d Deposits in Early IgA Nephropathy[J]. Clin J Am SocNephrol， 2018， 13：258-264.
[8] Rosenblad T， Rebetz J， Johansson M， et al. Eculizumab treatment for rescue of renal function in IgA nephropathy[J]. Pediatr.Nephrol.， 2014， 29(11)：2225., http://www.100md.com(杨艳 杨敏)